Section 906 CEO and CFO Certification

ABIOMED (ABMD)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

10-Q (Aug 6, 2014)10-Q (Feb 6, 2014)10-Q (Nov 8, 2013)10-Q (Aug 7, 2013)10-Q (Feb 6, 2013)10-Q (Nov 5, 2012)10-Q (Aug 6, 2012)10-Q (Feb 8, 2012)10-Q (Nov 7, 2011)10-Q (Aug 5, 2011)10-Q (Feb 4, 2011)10-Q (Nov 5, 2010)10-Q (Aug 5, 2010)10-Q (Feb 5, 2010)10-Q (Nov 6, 2009)10-Q (Aug 7, 2009)10-Q (Feb 9, 2009)10-Q (Nov 10, 2008)10-Q (Aug 11, 2008)10-Q (Feb 11, 2008)10-Q (Nov 8, 2007)10-Q (Aug 9, 2007)10-Q (Feb 8, 2007)10-Q (Nov 8, 2006)10-Q (Aug 9, 2006)10-Q (Feb 9, 2006)10-Q (Nov 9, 2005)10-Q (Aug 9, 2005)10-Q (Feb 8, 2005)10-Q (Nov 8, 2004)10-Q (Aug 9, 2004)10-Q (Feb 10, 2004)10-Q (Oct 30, 2003)10-Q (Aug 11, 2003)10-Q (Feb 14, 2003)10-Q (Nov 15, 2002)10-Q (Aug 28, 2002)10-Q (Aug 14, 2002)10-Q (Jan 24, 2002)10-Q (Oct 25, 2001)10-Q (Jul 25, 2001)10-Q (Jan 24, 2001)10-Q (Oct 26, 2000)10-Q (Jul 27, 2000)10-Q (Jan 19, 2000)10-Q (Nov 9, 1999)10-Q (Jul 28, 1999)10-Q (Feb 12, 1999)10-Q (Jan 8, 1999)10-Q (Oct 21, 1998)10-Q (Jul 29, 1998)10-Q (Jan 27, 1998)10-Q (Oct 27, 1997)10-Q (Oct 14, 1997)10-Q (Aug 7, 1997)10-Q (Feb 6, 1997)10-Q (Oct 24, 1996)10-Q (Jul 24, 1996)10-Q (Feb 6, 1996)10-Q (Oct 27, 1995)

8-K

Other

ABIOMED 10-Q 2009

Documents found in this filing:

Section 906 CEO and CFO Certification

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. § 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of ABIOMED, Inc., (the “Company”) for the quarter ended December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned President and Chief Executive Officer, and Corporate Controller, of the Company, certifies, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Michael R. Minogue				/s/ Robert L. Bowen
Chairman, President and Chief Executive Officer				Vice President and Chief Financial Officer
Date: February 9, 2009				Date: February 9, 2009

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

ABIOMED (ABMD)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: